These final results, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two help the principle of targeting ACKR3 as a singular strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-linked disorders. We independently research, assessment, and https://wernery062wnf8.wikihearsay.com/user